new_0222_0621|TLIS|Short Name|0|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment
new_0222_0621|TLIS|Long Name|1|1|Talis Biomedical Corp Total Current Assets (Quarterly) (USD)|Talis Biomedical Corp Cash and Short Term Investments (Quarterly) (USD)|Talis Biomedical Corp Inventories (Quarterly) (USD)|Talis Biomedical Corp Net PP&E (Quarterly) (USD)|Talis Biomedical Corp Goodwill and Intangibles (Quarterly) (USD)|Talis Biomedical Corp Total Liabilities (Quarterly) (USD)|Talis Biomedical Corp Total Current Liabilities (Quarterly) (USD)|Talis Biomedical Corp Total Long Term Liabilities (Quarterly) (USD)|Talis Biomedical Corp Total Deposits (Quarterly) (USD)|Talis Biomedical Corp Book Value (Quarterly) (USD)|Talis Biomedical Corp Retained Earnings (Quarterly) (USD)|Talis Biomedical Corp Treasury Stock (Quarterly) (USD)|Talis Biomedical Corp EV to Revenues|Talis Biomedical Corp EV to Earnings|Talis Biomedical Corp EV to Free Cash Flow|Talis Biomedical Corp EV to Assets (Quarterly)|Talis Biomedical Corp PS Ratio|Talis Biomedical Corp PE Ratio|Talis Biomedical Corp Price to Book Value|Talis Biomedical Corp PEG Ratio|Talis Biomedical Corp Debt to Equity Ratio|Talis Biomedical Corp Dividend Yield|Talis Biomedical Corp Shareholder Yield (TTM)|Talis Biomedical Corp Percent of Shares Outstanding Short|Talis Biomedical Corp Total Receivables (Quarterly) (USD)|Talis Biomedical Corp Total Payables (Quarterly) (USD)|Talis Biomedical Corp Total Capital Stock (Quarterly) (USD)|Talis Biomedical Corp Return on Invested Capital|Talis Biomedical Corp Quality Ratio Score|Talis Biomedical Corp Momentum Score|Talis Biomedical Corp Beta (1Y)|Talis Biomedical Corp Sustainable Growth Rate (TTM)|Talis Biomedical Corp Institutional Investor Ownership Percentage|Talis Biomedical Corp Average Diluted Shares Outstanding (Quarterly)|Talis Biomedical Corp Total Employees (Annual)|Talis Biomedical Corp EPS Diluted (Quarterly) (USD)|Talis Biomedical Corp SG&A Expense (Quarterly) (USD)|Talis Biomedical Corp Shares Outstanding|Talis Biomedical Corp Repurchase of Capital Stock (Quarterly) (USD)|Talis Biomedical Corp Ordinary Shares Number (Quarterly)|Talis Biomedical Corp Payout Ratio|Talis Biomedical Corp Quick Ratio (Quarterly)|Talis Biomedical Corp Normalized Diluted EPS (Quarterly) (USD)|Talis Biomedical Corp Stock Buybacks (Quarterly) (USD)|Talis Biomedical Corp Effective Tax Rate (TTM)|Talis Biomedical Corp Return on Equity|Talis Biomedical Corp Net Income (TTM) (USD)|Talis Biomedical Corp Revenue (TTM) (USD)|Talis Biomedical Corp Dividend Per Share (Quarterly) (USD)|Talis Biomedical Corp Revenue (Quarterly) (USD)|Talis Biomedical Corp Gross Profit (Quarterly) (USD)|Talis Biomedical Corp Pre-Tax Income (Quarterly) (USD)|Talis Biomedical Corp Net Income (Quarterly) (USD)|Talis Biomedical Corp Net Interest Income (Quarterly) (USD)|Talis Biomedical Corp Price (USD)|Talis Biomedical Corp Total Return Price (USD)|Talis Biomedical Corp Enterprise Value (USD)|Talis Biomedical Corp 30-Day Average Daily Volume|Talis Biomedical Corp 1 Year Price Returns (Daily)|Talis Biomedical Corp Short Interest|Talis Biomedical Corp PE Ratio (Forward)|Talis Biomedical Corp PE Ratio (Forward 1y)|Talis Biomedical Corp PS Ratio (Forward)|Talis Biomedical Corp PS Ratio (Forward 1y)|Talis Biomedical Corp Quarterly EPS Estimates (USD)|Talis Biomedical Corp Quarterly Revenue Estimates (USD)|Talis Biomedical Corp Quarterly EPS Surprise|Talis Biomedical Corp Quarterly Revenue Surprise|Talis Biomedical Corp Quarterly Actual EPS (USD)|Talis Biomedical Corp Quarterly Actual Revenue (USD)|Talis Biomedical Corp Revenue Estimates for Current Fiscal Year (USD)|Talis Biomedical Corp Revenue Estimates for Next Fiscal Year (USD)|Talis Biomedical Corp Price Target (USD)|Talis Biomedical Corp Consensus Recommendation|Talis Biomedical Corp Price Target Num Estimates|Talis Biomedical Corp EPS Estimates for Current Fiscal Year (USD)|Talis Biomedical Corp EPS Estimates for Next Fiscal Year (USD)|Talis Biomedical Corp Research and Development Expense (Quarterly) (USD)|Talis Biomedical Corp Reconciled Depreciation (Quarterly) (USD)|Talis Biomedical Corp Non-Operating Interest Expense (Quarterly) (USD)|Talis Biomedical Corp Land and Improvements (Quarterly) (USD)|Talis Biomedical Corp Buildings and Improvements (Quarterly) (USD)|Talis Biomedical Corp Other Properties (Quarterly) (USD)|Talis Biomedical Corp Machine, Furniture & Equipment (Quarterly) (USD)
new_0222_0621|TLIS|Unit|2|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric
new_0222_0621|TLIS||4|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|monthly|quarterly|quarterly|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly
new_0222_0621|TLIS||5|5|127.8|127.8|0|127.8|0|127.8|127.8|127.8|0|127.8|127.8|0|0|0|1.44357976654|0|0|0|1.44|0|0|1.44357976654|0|15.347826087|127.8|127.8|127.8|0|0|0|0|0|30.6363636364|91.2857142857|0|91.2857142857|91.2857142857|30.5555555556|0|127.8|0|0|91.2857142857|91.3333333333|0|0|91.25|0|0|0|0|91.2857142857|91.2857142857|0|1.44357976654|1.44357976654|1.44357976654|1.44298245614|1|15.347826087|0|0|1.44357976654|1.44357976654|91.25|91.25|91|91|91|91|24.8|22.9090909091|25.3333333333|21.7142857143|25.3333333333|26.5714285714|25.2|91.2857142857|91.2857142857|0|0|0|127.8|183
new_0222_0621|TLIS||6|6|5|5|0|5|0|5|5|5|0|5|5|0|0|0|257|0|0|0|225|0|0|257|0|23|5|5|5|0|0|0|0|0|11|7|0|7|7|9|0|5|0|0|7|6|0|0|4|0|0|0|0|7|7|0|257|257|257|228|4|23|0|0|257|257|8|8|3|3|3|3|15|11|12|14|12|14|10|7|7|0|0|0|5|2
new_0222_0621|TLIS||7|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly
new_0222_0621|TLIS|201912|201912|201912|24.107|21.604||1.535||46.873|4.037|42.836||-21.14|-81.776||||||||||||||1.806|1.566|0|||||||4.3603||-1.7512|1.764|||19.6799|||-1.7512|||||||||-7.636|-7.636|0.044||||||||||||||||||||||||6.946|0.187||||2.293|0.663
new_0222_0621|TLIS|202003|202003|202003||||||||||||||||||||||||||||||||||4.3603||-1.6912|2.08||||||-1.6912|0||||||||-7.374|-7.374|||||||||||||||||||||||||5.714|0.185|||||
new_0222_0621|TLIS|202006|202006|202006||||||||||||||||||||||||||||||||||4.3603||-2.304|2.66||||||-2.304|0||||||||-10.046|-10.046|||||||||||||||||||||||||8.184|0.193|||||
new_0222_0621|TLIS|202009|202009|202009|106.004|55.406||9.157||181.194|13.717|167.477||-65.942|-128.71||||||||||||||0.334|3.958|0|||||||4.3603||-6.7688|3.058|||19.6799|||-6.7688|0|||-54.57|||||-29.514|-29.514|||||||||||||||||||||||||36.011|0.186||||3.915|0.83
new_0222_0621|TLIS|202012|202012|202012|188.724|138.483||9.681||306.976|16.026|290.95||-108.571|-172.906||||||||||||||0.471|4.906|0|||||||19.6799|136|-2.2457|5.305|||19.6799|||-2.2457||||-91.13|||||-44.196|-44.196||||||||||||-0.77|0.2334|-3470.1299|-0.1628|-27.49|0.233|10.9381|||||-11.52||39.11|0.199||||4.441|0.848
new_0222_0621|TLIS|202102|202012|202012|||||||||||||||-3.1924|||||||0||3.5558|||||||||4.3816|||||25.6362|||||||||||||||||17.26|17.26|303.9978|||911572|||52.1179|12.6305||||||||||||||||||||
new_0222_0621|TLIS|202103|202103|202103|391.322|348.012||10.112||46.849|46.849|0||356.33|-233.398||||0.1647||||0.9245|||0||9.1811|0|10.826|0.005|||||||13.1107||-4.61|7.327|25.6376||25.6376|||-4.61|-233.348|||-144.248|||||-60.492|-60.492||12.85|12.85|-18.5658|405883||2353813|||38.8037|9.4039|-0.7828|5.375|-488.9116|30.2326|-4.61|7|72.051|119.5488|16.75|2|4|-1.47|-1.3809|60.193|0.216||||10.112|
new_0222_0621|TLIS|202104|202103|202103|||||||||||||||0.3581||||0.8634|||0||8.0017|||||||||||||||||||||||||||||||12|12|-40.3578|210244.9||2051452|||36.2369|8.7818|||||||75.7482|115.5181|16.5|2|4|-1.7363|-1.408|||||||
new_0222_0621|TLIS|202105|202103|202103|||||||||||||||0.8722||||0.7008|||0||7.9865||||||||||||||25.6376|||||||||||||||||9.74|9.74|-98.2988|96908.6||2047547|||29.4123|7.1279|||||||64.2807|106.6569|14.75|2|4|-3.178|-1.5182|||||||
new_0222_0621|TLIS|202106|202106|202106|353.865|313.458||23.925||85.806|72.629|13.177||293.729|-297.87||||0.2239||||0.9647|||0||7.0434|0.117|11.695|0.005||||||97.5054|25.6482||-2.51|9.983|25.6904||25.6904|||-2.51|0.802|||-198.674|||||-64.472|-64.472||11.03|11.03|-30.0899|273422.3||1809468|||33.3763|8.0886|-0.9113|0|-175.4428||-2.51|0.117||||||||54.495|0.194||||23.925|
new_0222_0621|TLIS|202107|202106|202106|||||||||||||||0.3635||||0.9009|||0||6.4621|||||||||98.0953||||||||||||||||||||||10.3|10.3|-48.8439|440609.1667||1660130|||31.1674|7.5533||||||||||||||||||||
new_0222_0621|TLIS|202108|202106|202106|||||||||||||||0.7918||||0.705|||0||5.2183|||||||||98.1301|||||25.6909|||||||||||||||||8.06|8.06|-106.3863|413091.7333||1340633|||24.3897|5.9107|||||||10.2198|65.563|9.6667|3|3|-7.3084|-2.4769|||||||
new_0222_0621|TLIS|202109|202109|202109|277.557|273.603||23.791||44.304|31.342|12.962||258.789|-336.288||||0.6487||||0.627|||0||5.3478|0.219|5.388|0.005||||||70.3646|25.7871||-1.49|12.792|25.963||25.963|||-1.49|0|||-207.578|||||-38.418|-38.418||6.25|6.25|-111.3312|237996.3667||1388457|||19.1129|4.6319|-1.3985|1.4613|-6.5458|-85.0817|-1.49|0.218|11.2541|61.8766|8.5|3.3333|2|-8.0046|-3.2682|25.841|0.231||||23.791|
new_0222_0621|TLIS|202110|202109|202109|||||||||||||||0.7849||||0.5367|||0||6.6307|||||||||70.3653||||||||||||||||||||||5.35|5.35|-134.698|143174.1333||1721533|||16.3607|3.9649|||||||10.6241|56.5432|7|3.3333|2|-8.0079|-3.2849|||||||
new_0222_0621|TLIS|202111|202109|202109|||||||||||||||0.8773||||0.4754|||0||2.6294|||||||||69.4569|||||26.2886|||||||||||||||||4.68|4.68|-150.5694|211914.5333||691232|||14.4912|3.5119|||||||8.49|35.0326|6|3.3333|2|-8.3362|-4.0101|||||||
new_0222_0621|TLIS|202112|202112|202112|||||||||||||||0.98||||0.4073|||0||2.909|||||||||68.1939||||||||||||||||||||||4.01|4.01|-168.1827|217257.1333||764729|||3.0091|1.4801|-1.284|1.3333|||||8.49|||||-8.3362||||||||
new_0222_0621|TLIS|202201|202112|202112|||||||||||||||1.1423||||0.2997|||0||1.9905|||||||||64.3973||||||||||||||||||||||2.95|2.95|-196.0486|135257.6333||523275|||2.3243|1.0889|||||||33.3659||4.5|3.6667|2|-4.3867||||||||
new_0222_0621|TLIS|202202|202112|202112|||||||||||||||1.2787||||0.2093|||0|||||||||||||||||||||||||||||||||2.06|2.06|-219.4455|98722.5|-91.5884||||1.623|0.7604||||||||||||||||||||
new_0222_0621|TLIS|202203|202203|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-1.23|1.2||||||||||||||||||
new_0222_0621|TLIS|202206|202206|202206|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-1.195|4||||||||||||||||||
new_0222_0621|TLIS|202209|202209|202209|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-1.12|6.3||||||||||||||||||
new_0222_0621|TLIS|202212|202212|202212|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.935|28.5||||||||||||||||||